Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: ANI Pharmaceuticals | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: ANI Pharmaceuticals

Revenues up 19% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ANI Pharmaceuticals
 
2Q Revenues: $6.2 million (+19%)

2Q Loss: $4.6 million (earnings were $35.4 million 2Q12)

YTD Revenues: $11.7 million (+17%)

YTD Loss: $4.3 million (loss of $35.1 million YTD12)

Comments: Growth in the quarter was primarily due to a 26% increase in prescription sales to $3.9 million. Contract sales and royalties increased 7% to $2.2 million in the quarter. R&D costs increased 108% to $0.4 million, due to a Generic Drug User Fee Act (GDUFA) fee of $52,000 in the quarter.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters